Brachytherapy Market Is Anticipated To Grow At A 4.06% CAGR from 2014 to 2025: Grand View Research, Inc.

The global brachytherapy market is expected to reach USD 486.9 million by 2025, according to a new report by Grand View Research, Inc. This growth can be attributed to increasing geriatric population, unhealthy lifestyle, mergers & acquisitions, and unmet needs of cancer care in low- and middle-income countries.

Furthermore, there is rising competition in the brachytherapy market due to technological advancements and presence of players, such as C.R. Bard, Inc.; Elekta AB (pub); IsoRay, Inc.; and Argon Medical Devices, Inc. Hence, brachytherapy market is expected to witness lucrative growth during the forecast period.

According to American Brachytherapy Society, safety and efficacy of brachytherapy treatment over other cancer treatments, such as chemotherapy and surgery, is expected to boost the market.

U.S. brachytherapy market, by type, 2014 - 2025 (USD Million)



Browse full research report on Brachytherapy Market: http://www.grandviewresearch.com/industry-analysis/brachytherapy-devices-market

Further Key Findings From the Study Suggest:

  • In 2016, High-Dose Rate (HDR) brachytherapy dominated the market. Furthermore, the HDR brachytherapy segment is anticipated to grow at the fastest CAGR owing to factors such as growing incidence of breast cancer, unhealthy lifestyle, increase in research initiatives, and introduction of technological advancements by key players
  • HDR brachytherapy decreases radiation exposure time as its implantation is temporary, making it more convenient for patients than LDR brachytherapy in which radiation sources are permanently implanted
  • The application segment comprises of prostate cancer, breast cancer, and gynecological cancer. The breast cancer segment is expected to exhibit lucrative growth by 2025 with a CAGR of more than 5%, as breast cancer is the second most common cancer according to GLOBOCAN
  • Geographic expansion into Europe, Asia Pacific, and Middle East & Africa by well-established players is anticipated to promote fastest growth in the region
  • Asia Pacific is the fastest growing region due to increased prevalence of cancer and increasing access to radiation therapy, such as Esteya, an electronic brachytherapy system for treating skin cancer
  • Some of the key players in the brachytherapy market are Elekta AB (pub); Varian Medical Systems, Inc.; IsoRay Medical, Inc.; iCAD, Inc.; and Eckert & Ziegler BEBIG
  • In August 2016, Eckert & Ziegler BEBIG acquired BrachySolutions BVBA, one of the largest European prostate seed distributors, for portfolio enhancement. Through this acquisition, the company has secured a strong position in Europe as a seed manufacturer.
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-brachytherapy-market                                                                                    
About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.


For more information: http://www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more